formulations of anti-microbials Flashcards
1
Q
characteristics of a topical drug
A
- low MW (less than 500)
- moderately lipophilic (logP 1-4)
- effective at low dose (daily dose of less than 10mg)
2
Q
liquid formulations
A
- single-phase solutions/lotions
- rapid short term input of permeant into skin
- poor residence time on the skin
- evaporation of solvent (alcoholic vehicle)
EXAMPLES: erythromycin solution, clindamycin lotion
3
Q
semi-solid formulations
A
- ointments, gels, creams
- good residence time on the skin
- good acceptance from patients
semi-solid base: - hydrophobic (liquid paraffin, glycerides, waxes)
- hydrophilic (polyethylene glycol PEG)
4
Q
ointments
A
- hydrophobic, fatty preparations
- highly occlusive (non-permeable)
- used on dry lesions
- prolonged drug delivery
- messy to use
EXAMPLES: mupirocin, fusidic acid (staphylococcus infection: impetigo)
5
Q
gels
A
- formed from a liquid phase that is thickened with other components (i.e. PEG, polymers: carbomer)
- liquid phase maybe alcoholic, solvent may evaporate
EXAMPLE: metronidazole gel (rosacea)
6
Q
creams
A
- made of 2 phased emulsion: water-in-oil or oil-in-water
- water-in-oil emulsions less greasy than ointments
- easier to apply
- can be washed off
- less occlusive than ointments
- less beneficial in dry skin conditions
EXAMPLES: mupirocin, neomycin, fusidic acid
7
Q
solid formulations
A
- spray powders
- incorporate a volatile solvent (ethanol) that dissolves some drug prior to evaporation
EXAMPLE: miconazole nitrate (fungal skin infection: athletes foot)
8
Q
nail solid formulations
A
- nail lacquer
- keratolytic components (urea) to increase diffusion of the drug through the nail plate
EXAMPLE: amorolfine
9
Q
eye solutions
A
- easy to administer
- homogeneous (better dose uniformity)
- rapidly drained out of eye
- lack of efficacy
EXAMPLES: chloramphenicol, ciprofloxacin (corneal ulcers)
10
Q
eye ointments
A
- mainly used of lipophilic excipients (petrolatum, lanolin)
- reduce drug drainage caused by tear flow
- increase of corneal residence time
- sustained drug release (2-4 hrs)
- more difficult to administer than solutions
- blurring of vision
EXAMPLES: chloramphenicol, ciprofloxacin
11
Q
ear solutions
A
- viscous formulations
- increase residence time of the formulation
- prolonged contact with the area of infection
EXAMPLES: chloramphenicol, clotrimazole (otitis)
12
Q
nose formulations
A
- creams, ointments
- mucocilliary clearance (removal of the drug from the nasal cavity)
- bioadhesion needed for increased nasal residence time
EXAMPLES: mupirocin, chlorhexidine + neomycin (staphylococci)
13
Q
oropharyngeal formulations
A
- solutions, gels, suspensions, mucoadhesive buccal tablets
- suspensions deposit antimicrobial drug on mucosa surface
- improvement of residence time of drug but dissolution needed prior permeation
EXAMPLES: - miconazole gel and mucoadhesive tablets (fungal infections: thrush, candidiasis)
- Nystatin suspension (fungal)
- chlorhexidine mouth wash
14
Q
vagina formulations
A
- gels, creams, pessaries, ovules
- pessary: solid, single-dose formulation of ovoid shape
- ovules (vaginal capsules): solid single-dose formulations
- treatment of local infections with low dose than with oral administration
- no need of absorption of drugs for local action
- release of the drugs influenced by varying volumes of vaginal fluid
EXAMPLES: - clotrimazole (cream/pessary)
- antifungal miconazole (ovule)
- metronidazole (gel)
15
Q
oral administration
A
- drug absorption through epithelia and mucosa of GI tract
- most convenient and safest form
- possibility of irregular absorption of certain drugs